Current Drug Targets - Inflammation & Allergy

Continued as Inflammation & Allergy - Drug Targets

Personal Subscription
Volume: 3 Issue: 3, September

Preface [Hot Topic: Novel and Alternative Non-Steroidal Treatments for Asthmatic Inflammation (Guest Editor: Mario Cazzola)]

Volume:3   Issue: 3
Pp: ii-ii
Mario Cazzola
DOI: 10.2174/1568010X104030300ii
Published on: 01 March, 2012

Glycosaminoglycans and the Regulation of Allergic Inflammation

Volume:3   Issue: 3
Pp: 221-225
Mark J. Rose and Clive Page
DOI: 10.2174/1568010043343589
Published on: 01 March, 2012

Anti-IgE Monoclonal Antibody (Omalizumab) in the Treatment of Atopic Asthma and Allergic Respiratory Diseases

Volume:3   Issue: 3
Pp: 227-229
Gennaro D'Amato, Gennaro Liccardi, Paolo Noschese, Antonello Salzillo, Maria D'Amato and Mario Cazzola
DOI: 10.2174/1568010043343615
Published on: 01 March, 2012

The Potential of PDE4 Inhibitors in Respiratory Disease

Volume:3   Issue: 3
Pp: 231-236
Domenico Spina
DOI: 10.2174/1568010043343822
Published on: 01 March, 2012

Potential Role of Antibiotics in the Treatment of Asthma

Volume:3   Issue: 3
Pp: 237-242
Francesco Blasi, Roberto Cosentini, Paolo Tarsia and Luigi Allegra
DOI: 10.2174/1568010043343624
Published on: 01 March, 2012

Targeting Th2 Cells in Asthmatic Airways

Volume:3   Issue: 3
Pp: 243-255
Gaetano Caramori, Kazuhiro Ito and Ian M. Adcock
DOI: 10.2174/1568010043343750
Published on: 01 March, 2012

Chemokine Receptor Inhibitors as a Novel Option in Treatment of Asthma

Volume:3   Issue: 3
Pp: 257-261
Ian M. Adcock and Gaetano Caramori
DOI: 10.2174/1568010043343660
Published on: 01 March, 2012

Cytokine-Directed Therapy in Asthma

Volume:3   Issue: 3
Pp: 263-269
Masakazu Ichinose and Peter J. Barnes
DOI: 10.2174/1568010043343688
Published on: 01 March, 2012

Anti-Inflammatory Activities of α2-Agonists

Volume:3   Issue: 3
Pp: 271-277
Nicola A. Hanania and Robert H. Moore
DOI: 10.2174/1568010043343598
Published on: 01 March, 2012

Chemokines and Chemokine Receptors: Potential Therapeutic Targets in Multiple Sclerosis

Volume:3   Issue: 3
Pp: 279-290
Diane M. Muller, Michael P. Pender and Judith M. Greer
DOI: 10.2174/1568010043343732
Published on: 01 March, 2012

Peripheral and Central Mechanisms of Inflammatory Pain, with Emphasis on MAP Kinases

Volume:3   Issue: 3
Pp: 299-303
Ru-Rong Ji
DOI: 10.2174/1568010043343804
Published on: 01 March, 2012

Dendritic Cell-Based Therapies in the Bench and the Bedsides

Volume:3   Issue: 3
Pp: 305-310
Sk. Md. Fazle Akbar, Hidehiro Murakami, Norio Horiike and Morikazu Onji
DOI: 10.2174/1568010043343787
Published on: 01 March, 2012

Melanocortin Receptor Type 3 as a Potential Target for Anti-Inflammatory Therapy

Volume:3   Issue: 3
Pp: 311-315
Connie W. Lam and Stephen J. Getting
DOI: 10.2174/1568010043343606
Published on: 01 March, 2012

Molecular Therapeutic Targets in Inflammation: Cyclooxygenase and NF-κB

Volume:3   Issue: 3
Pp: 317-324
Teresa Krakauer
DOI: 10.2174/1568010043343714
Published on: 01 March, 2012

Cytokine and Nitric Oxide Production Following Severe Envenomation

Volume:3   Issue: 3
Pp: 325-332
Vera L. Petricevich
DOI: 10.2174/1568010043343642
Published on: 01 March, 2012